HomeMLTX • NASDAQ
add
MoonLake Immunotherapeutics
Previous close
$48.17
Day range
$46.00 - $48.87
Year range
$37.55 - $64.98
Market cap
2.96B USD
Avg Volume
234.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 43.11M | 232.23% |
Net income | -35.39M | -275.45% |
Net profit margin | — | — |
Earnings per share | -0.56 | -211.11% |
EBITDA | -43.08M | -232.06% |
Effective tax rate | -0.26% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 493.92M | -0.41% |
Total assets | 518.21M | 3.60% |
Total liabilities | 22.71M | 114.74% |
Total equity | 495.50M | — |
Shares outstanding | 63.06M | — |
Price to book | 6.22 | — |
Return on assets | -20.28% | — |
Return on capital | -20.88% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -35.39M | -275.45% |
Cash from operations | -25.27M | -173.22% |
Cash from investing | 58.28M | 133.42% |
Cash from financing | 183.10K | — |
Net change in cash | 32.87M | 117.90% |
Free cash flow | -18.84M | -536.95% |
About
Founded
2020
Headquarters
Website
Employees
50
